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Gamma aminobutric acid (GABA) is the major inhibitory neurotransmitter in the adult
brain and mechanisms of GABAergic inhibition have been intensely investigated
in the past decades. Recent studies provided evidence for an important role of
astrocytes in shaping GABAergic currents. One of the most obvious, but yet poorly
understood, mechanisms of the cross-talk between GABAergic currents and astrocytes
is metabolism including neurotransmitter homeostasis. In particular, how modulation
of GABAergic currents by astrocytes depends on key enzymes involved in cellular
metabolism remains largely unknown. To address this issue, we have considered two
simple models of neuronal culture (NC): nominally astrocyte-free NC and neuronal-
astrocytic co-cultures (ANCC). Miniature Inhibitory Postsynaptic Currents (mIPSCs) were
recorded in control conditions and in the presence of different enzyme blockers. We
report that enrichment of NC with astrocytes results in a marked increase in mIPSC
frequency. This enhancement of GABAergic activity was accompanied by increased
number of GAD65 and vGAT puncta, indicating that at least a part of the frequency
enhancement was due to increased number of synaptic contacts. Inhibition of glutamine
synthetase (Glns) (with MSO) strongly reduced mIPSC frequency in ANCC but had no
effect in NC. Moreover, treatment of ANCC with inhibitor of glycogen phosphorylase
(Gys) (BAYU6751) or with selective inhibitor of astrocytic Krebs cycle, fluoroacetate,
resulted in a marked reduction of mIPSC frequency in ANCC having no effect in
NC. We conclude that GABAergic synaptic transmission strongly depends on neuron-
astrocyte interaction in a manner dependent on key metabolic enzymes as well as on
the Krebs cycle.
Keywords: metabolism, GABAergic synapses, miniature inhibitory synaptic currents, astrocytes, glycogen
phosphorylase, glutamine synthetase, hippocampal neurons
Introduction
Gamma aminobutric acid (GABA) is the main inhibitory neurotransmitter in the mammalian
adult brain and is derived from glutamic acid by glutamate decarboxylase (GAD)
which is widely expressed in two isoforms, GAD65 and GAD67, the former in neurons
and the latter one both in neurons and astrocytes (Yoon and Lee, 2014). GABAergic
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inhibition in the phasic and tonic forms has been extensively
investigated in the past decades (Farrant and Nusser, 2005)
but its interdependence with cellular metabolism remain poorly
understood. Glutamate is a GABA precursor and the main
excitatory neurotransmitter in the CNS. It is synthesized from
glutamine, which can be considered as astrocytic precursor for
both neurotransmitters and is supplied directly by astrocytes
where it is catalyzed by glutamine synthetase (Glns; Bak et al.,
2006). Under physiological and in vitro conditions, Glns is
localized mainly in astrocytes but in some pathologies it may
also occur in neurons (Norenberg and Martinez-Hernandez,
1979; Derouiche and Ohm, 1994; Suárez et al., 1996). Glucose
in the brain is delivered from blood vessels to astrocytes
where it might be metabolized to glycogen (Cataldo and
Broadwell, 1986; Wender et al., 2000; Kong et al., 2002) or
transformed to lactate which, in turn, is released and absorbed
by neurons providing them with their primary energy substrate
(Magistretti and Pellerin, 1999). Glycogen in astrocytes can be
cleaved by glycogen phosporylase (Pyg) and metabolized to
lactate and/or provide substrates for Krebs cycle to produce
ATP and neurotransmitter precursors. In general, astrocytes,
besides their well-established functions in metabolism and
homeostasis, have been recognized as effective regulators of
synaptic transmission. In particular, astrocytes were shown to
be strongly involved in synaptogenesis (Diniz et al., 2012).
Interestingly, in a recent study, Suzuki et al. (2011) have shown
that astrocyte-neuron lactate transport plays a key role in LTP
maintenance and memory formation. Thus, metabolic processes
turn out to be critical regulators of synaptic plasticity which
is a substrate for learning and memory. Whereas plasticity
implicated in classic learning paradigms concerns mainly
glutamatergic transmission, recent studies clearly demonstrated
that GABAergic synapses also show a marked degree of
synaptic plasticity (for review: Flores and Méndez, 2014; Petrini
and Barberis, 2014; Wenner, 2014) although its mechanisms
and, in particular, involvement of astrocytic and neuronal
metabolic enzymes remain poorly understood. Several lines of
evidence indicate a variety of interactions between astrocytes
and GABAergic system. For instance, Ortinski et al. (2010)
have shown that astrocytosis may selectively reduce inhibitory
GABAergic currents due to diminished expression of Glns.
However, Kang et al. (1998) reported that a direct stimulation
of astrocytes potentiated miniature Inhibitory Postsynaptic
Currents (mIPSCs) in pyramidal neurons. Interestingly, release
of GABA from astrocytes has been implicated in regulation
of tonic form of inhibition (Lee et al., 2010). Recently,
Christian et al. (2013) have demonstrated that endozepines
released from astrocytes potentiate GABAergic currents in
RT thalamic nucleus. It is noteworthy that astrocytes express
GABAA and GABAB receptors (Lee et al., 2011) indicating
that interaction between astrocytes and GABAergic cells
maybe reciprocal.
Thus, cross-talk between GABAergic synapses and
astrocytes may involve a wealth of potential mechanisms
including metabolism control, modulation of balance between
neurotransmitters and their precursors and modulation of both
neurons and astrocytes by several gliotransmitters (for review by
Sahlender et al., 2014). It is thus difficult to precisely indicate the
role of specific regulators in the neuronal-astrocytic cross-talk.
In particular, how the regulation of GABAergic transmission
by astrocytes depends on major enzymes regulating astrocytic
metabolism (e.g., Pyg) or neurotransmitter homeostasis
(e.g., Glns) remains poorly understood. To address these
issues we have considered simple models of neuronal culture
(NC): nominally without astrocytes (NC) and neuronal-
astrocytic co-cultures (ANCC) and measured mIPSCs in control
conditions and in the presence of pharmacological agents
blocking enzymes of interest. We report that enrichment of
NC with astrocytes results in a marked increase of mIPSC
frequency. This increased synaptic activity was accompanied
by increase of GAD65 and vGAT puncta co-localizing with
cells stained with neuronal marker tubulin β3. Inhibition of
Glns (with l-methionine-sulfoxide, MSO) strongly reduced
mIPSC frequency in astrocyte-neuron co-culture whereas
Glns inhibitor in NC was ineffective. Moreover, treatment
of ANCC with inhibitor of Pyg or with selective inhibitor of
astrocytic Krebs cycle fluoroacetate (FA), resulted in reduction
of mIPSC frequency in ANCC having no effect in NC. We
conclude that GABAergic synaptic transmission strongly
depends on neuron-astrocyte interaction in a manner dependent
on key metabolic enzymes (Glns, Pyg) as well as on the
Krebs cycle.
Materials and Methods
Cell Culture
All performed procedures on rats were approved by The
Scientific Research Ethical Committee (permission#118/2010).
Cell cultures were prepared from P0-P1 Wistar rat pups using
methodology described in detail elsewhere (Mozrzymas et al.,
2011) with slight modifications. Briefly, hippocampi were
quickly removed from brains in ice cold dissociation medium
DM (in mM: 81.8 Na2SO4, 30 K2SO4, 5.8 MgCl2, 0.25 CaCl2;
1 HEPES, 20 Glucose; 1 Kynureic Acid, 0.001% Phenol Red).
Dissected hippocampi were treated twice for 15 min with
100 U papain, rinsed three times in DM and plating medium
(MEM, 10% FBS, antibiotics). Next, hippocampal tissue was
mechanically dissociated with fire polished glass pipettes. Cell
suspension was then transferred to 10 ml OPTI-MEM and
centrifuged at 163 g. Obtained cell pellet was then re-suspended
in the plating medium and plated at density 3.15 × 104 cells at
18 mm diameter cover slips, covered with poly-Lysine (Sigma-
Aldrich, Germany) and laminin (Roche, France). After 2 h,
medium was changed to NA/B-27 medium (culture growth
medium) (Neurobasal-A w/o Phenol Red, 2% B-27 Supplement,
1% Penicillin/Streptomycin, 0.5 mM Glutamine, 12.5 µM
Glutamate, 25 µM β-mercapto-ethanol. After 48 h, to prevent
astrocytic growth, AraC was added at a final concentration
of 25 µM. Primary cell culture obtained using this protocol
contained a small (10–15%) astrocyte contamination. To prepare
the astrocyte-neuron co-cultures (ANCC), astrocytes were added
to NC at final density of approximately 4 × 104 cells/cm2.
All electrophysiology and immunofluorescence experiments
were performed within 13 and 16 days in culture in the case
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of ANCC and not earlier than 24 after astrocytes addition to
NC (to avoid suppression of neurons by astrocytic overgrowth).
Astrocytes were prepared from the same animals as neurons. All
cells, after dissociation of hippocampi, were cultured in plastic
25 ml flask in DMEM (IITD, Poland) supplemented with 10%
of fetal bovine serum (Gibco, USA), 2 mM glutamine, 5.55 mM
glucose (Chempur, Poland) and 1% Penicillin/Streptomycin.
To remove remaining fibroblasts, astrocyte growth medium
was supplemented with d-Valine and, to eliminate neuronal
contamination from astrocyte culture, two passages were
performed, once a week before the use in the co-cultures.
Unless otherwise stated, all chemicals were from Sigma-Aldrich,
Germany.
Electrophysiological Recordings
GABAergic mIPSC were recorded in the whole-cell
configuration of the patch-clamp technique at the membrane
voltage of −70 mV, using the Axopatch 200B amplifier
(Molecular Devices Corporation, USA). Signals were acquired
at 50 kHz following low-pass filtering at 5 kHz using Digidata
1440A (Molecular Devices Corporation) interface and pClamp10
software (Molecular Devices Corporation). The intrapipette
solution contained (in mM): 137 CsCl, 1 CaCl2, 2 MgCl2, 11
BAPTA (tetra cesium salt), 2 ATP and 10 HEPES, pH 7.2
with CsOH. The composition of the external solution was
the following (in mM): 137 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2,
24 glucose and 10 HEPES, pH 7.2 with NaOH. mIPSCs were
recorded in the presence of 1 µM tetrodotoxin (TTX) to suppress
neuronal excitability and 10 µM Kynurenic acid was added to
the external saline to block the glutamatergic currents (in our
conditions mainly those mediated by AMPA receptors). The rise
time kinetics of mIPSCs was described as 10–90% onset time and
the decay time course was fitted with a sum of two exponential
functions:
Tdec(t) = A1e
τ1
t + A2e
τ2
t (1)
where τ1, τ2 are the time constants and A1, A2 are respective
amplitudes. Based on this fit, the weighted decay time constant
was calculated: τmean = a1τ1 + a2τ2, where a1, a2 are normalized
amplitudes (a1 = A1/(A1 + A2), a2 = A2/(A1 + A2). Detection
and analysis of mIPSC time course was performed with Clampfit
10 software (Molecular Devices Corporation, USA). To construct
the cumulative distribution, data are first sorted in the ascending
order yielding the array of the X values. For any X, Y is
determined as the ratio of counts of X values which are smaller
or equal to the considered X and the total number of counts
for X values. Statistical significance was assessed using unpaired
two-tailed T-test accompanied by Fisher test. Differences
between data sets were considered statistically significant when
p ≤ 0.05. To test the impact of glycogen phosphorylase (Gys),
glutamine synthase (Glns) and aconitase, for each considered
enzyme, recordings were performed on cells divided into two
groups: control (NCC or ANCC) and cells treated by medium
supplemented with respective inhibitors (5 µM BAY U6751
for 30 min; 1 mM-methionine sulfoxide, MSO for 30 min;
1 µM FA for 30 min) and α-Cyano-4-hydroxycinnamic acid
(4-cin, a blocker of monocarboxylate transporters, 100 µm
for 15 min, to block lactate transport between astrocytes and
neurons). After treatment, coverslips with cells were transferred
to external solution containing respective inhibitor (at the same
concentration as during treatment) to perform the whole cell
recordings. All chemicals, unless otherwise stated, were from
Sigma-Aldrich-Germany.
Immunofluorescence
Immunofluorescence staining was performed for NC, ANCC and
astrocyte cultures after fixation with 4% PFA (Sigma-Aldrich,
Germany) in PBS. Prior to application of the primary antibodies,
to prevent non-specific reaction, fixed cells were incubated
with 5% BSA in PBS for 30 min. Reactions with primary
antibodies were run overnight at 4◦C. Secondary antibodies
in 5% BSA were applied next day for 1 h. Cell nuclei were
visualized with DAPI. After each step, fixed cells were washed
with 0.1% triton (BDH Chemicals, England) and three times
with PBS. Cultures snapshots were gathered with Olympus
fluo-view 1000 confocal microscope (final magnification 600×
with objective 60× and ocular 10×) and analyzed with
Olympus FV 1000 viewer software and a freeware ImageJ
software together with SynaptcountJ, NeuronJ and Bioformats
plugins. Changes in the density of synaptic puncta stained
with vGAT, gephyrin or GAD65 were assessed by counting
their number per single cell stained with neuronal marker
tubulin β3, and calculated as puncta/cell. More precisely, the
number of puncta was determined only for the cell area
clearly stained against tubulin β3. To assess the number of
immunostained points we used the highest possible power
(600×, objective 60×) but at this magnification only a few
neurons could be observed in a single snapshot. To make our
assessment of puncta/cell more representative, for each cell
culture preparation, 8–10 different snapshots were acquired
both for NC and ANCC and for each snapshot the average
number of puncta/neuron was calculated. Considering that our
data have been collected from five preparations, the NC and
ANCC groups were represented by 40–50 values determined
from the snapshots. To compare these data sets, the unpaired,
two tail T-test was applied. Primary antibodies and their
dilution: Gephyrin monoclonal mouse 1:50 (Cat. No. 147
111), GAD65 polyclonal rabbit 1:1000 (Cat. No. 198 102), β3-
tubulin polyclonal rabbit 1:2000 (Cat. No. 302 302), vGAT
polyclonal rabbit crude antiserum 1:1000 (Cat. No. 131 002)
(all from Synaptic Systems, Germany), β3-tubulin monoclonal
mouse (T5076) 1:1000, GFAP polyclonal rabbit (G9269) 1:1000
and GFAP monoclonal (G6171) mouse 1:000 (all three from
Sigma, Germany). Primary antibodies were visualized with
FITC 1:1000 (F6005, F5636) or TRITC 1:1000 (T6778, T6528)
conjugated secondary antibody against rabbit or mouse (Sigma,
Germany).
Results
Astrocytes Increase GABAergic Activity in
Cultured Hippocampal Neurons
mIPSCs were measured in the whole-cell mode at −70 mV
and in the neuronal cell culture (NC) the averaged current
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frequency was 0.13 ± 0.02 Hz (n = 15) and the mean mIPSC
amplitude was 50.72 ± 2.43 pA (n = 15). Time course was
characterized by a rapid onset (10–90% rise time = 1.51 ±
0.05 ms, n = 15) and a biphasic decay with the weighted decay
time constant (39.89 ± 1.4 ms, n = 15). Interestingly, addition
of astrocytes to the NC resulted in a dramatic (nearly fourfold,
Figures 1A/A1) increase in mIPSC frequency to 0.42± 0.079 Hz
(n = 15) in ANCC (p < 0.05) when recordings were made at
least 24 h after addition of astrocytes (See Section Materials and
Methods). However, addition of astrocytes did not affect the
mean mIPSC amplitude (49.39 ± 4.24 pA, n = 15, p > 0.05).
Moreover, the time course of mIPSCs (10–90% rise time and
weighted decaying time constants) were not significantly altered
in the ANCC with respect to those determined for NC (data not
shown, p > 0.05, n = 15). The results of electrophysiological
analysis suggest that the presence of astrocytes does not affect
the postsynaptic properties of mIPSCs (amplitude and time
course) and therefore the increased frequency might result
either from increased number of GABAergic synapses and/or
increased quantal release. To address the former possibility,
we have performed the immunofluorescence on five different
cell lines, staining for GAD65 (glutamate decarboxylase). This
staining revealed a significant 45% increase in GAD65 puncta
in ANCC neurons (210 ± 19 puncta/cell, n = 44 in NC
and 305 ± 25 puncta/cell, n = 50 in ANCC, p < 0.05). To
provide further evidence that astrocyte enrichment gives rise to
increased number of synapses, immunofluorescence staining was
additionally made for vGAT (GABAergic presynaptic marker)
and gephyrin (key postsynaptic scaffold protein of GABAergic
synapse). Analysis of vGATpuncta confirmed their significantly
increased number in ANCC by 31% Figure 2 (336 ± 33
puncta/cell, n = 43 in NC and 443 ± 39 puncta/cell, n =
46 in ANCC, p < 0.05). Increase in number of gephyrin
spots in ANCC compared to NC, was slightly above the
border line of statistical significance level (p = 0.073 data not
shown). These data indicate that enrichment of the NC with
astrocytes results in an enhanced mIPSC frequency which is
accompanied, to a smaller extent, by increased number of
GABAergic synaptic puncta.
The Effect of Glycogen Phosphorylase Inhibition
To test whether observed effect of astrocytes on GABAergic
currents depended on astrocytic metabolism we first checked
the impact of Pyg inhibition on GABAergic synaptic currents.
To this end, mIPSCs were recorded in NC and ANCC in
control conditions and after incubation with the inhibitor of this
enzyme BAY U6751 (5 µM, see Section Materials and Methods).
In NC, no effect of BAY U6751 was observed on mIPSC
frequency (Figure 3A) or time course (p > 0.05, n = 10, data
not shown). However, this inhibitor strongly reduced mIPSC
frequency in ANCC Figures 3B,B1 (0.45 ± 0.008 Hz, n = 10
in control; 0.14 ± 0.02 Hz, n = 10 in BAY U6751) but, again,
did not affect the time course of mIPSC (data not shown).
The scatter plot (Figure 3B1) shows that the presence of BAY
U6751 has limited the frequency distribution to lowest values
observed in ANCC. Moreover, administration of Pyg inhibitor
to ANCC caused a reduction of mIPSC frequency which was
comparable to the difference betweenmIPSC frequency in ANCC
FIGURE 1 | Supplementation of neuronal culture (NC) with astrocytes
strongly up regulates mIPSC frequency. (A), Typical traces recorded from
neurons in NC and from ANCC. Lower traces in (A) show examples of the same
recordings in an expanded time scale to show kinetic features of mIPSCs (rapid
onset and relatively slow decaying phase). (B), statistics for mIPSC frequency in
NC (filled bar) and in ANCC (open bar). (B1), scattered plot of data for NC (filled
circles) and for NC (open circles). Asterisks indicate significant difference
between respective groups.
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FIGURE 2 | Supplementation of neuronal culture (NC) with astrocytes
increases the number of synaptic puncta. (A,B), typical examples of
staining for synaptic puncta with antibodies against GAD65 (red) in NC (A) and
ANCC (B). Green color reflects tubulin β3 staining in all graphs. (C) Statistics for
the number of GAD65 puncta per neuron in NC (filled bar) and in ANCC (open
bar). (D,E), examples of staining for synaptic puncta with antibodies against
vGAT (orange) in NC (D) and ANCC (E). (F), Statistics for the number of
vGATpuncta per neuron in NC (filled bar) and in ANCC (open bar). Asterisks
indicate significant difference between respective groups, spacebar in pictures
represents 100 µm.
and NC in control conditions. Interestingly, mIPSC amplitude in
NC and ANCC was significantly increased following treatment
with BAY U6751 (Figures 3C–D2, from 50.77 ± 2.42 pA
in control to 67.72 ± 4.44 in BAY U6751 n = 10 for NC
and from 51.95 ± 4.24 pA in control to 59.5 ± 4.8 pA in
BAY U6751 n = 10 for ANCC). However, as shown in the
scatter plots and cumulative distributions (Figures 3C–D2),
the measured values of amplitudes largely overlapped with
only a few extra-large amplitude values in the presence of
BAY U6751. Lactate, released from astrocytes due to glycogen
breakdown, is believed to be taken up by neurons by means of
MCT transporters. To verify to what extent observed neuronal-
astrocyte cross talk relies on the MCT activity in our model, we
used a MCT blocker 4-cin (α-Cyano-4-hydroxycinnamic acid).
Application of 4-cin during incubation and its presence during
electrophysiological measurements at a final concentration of
0.1 mM resulted in a reduction of mIPSC frequency both in
NC and NACC (from 0.14 ± 0.02 Hz, n = 15 in control
to 0.05 ± 0.01 Hz, n = 8 after 4-cin treatment NC and
from 0.45 ± 0.008 Hz, n = 10–0.1 ± 0.01 Hz, n = 12 in
ANCC in all cases p < 0.05, Figure 4). This reduction was
associated with the disappearance of high and appearance of
extra low frequency values in the scatter plots (Figures 4A1,B1).
Interestingly, treatment with 4-cin significantly decreased also
mIPSC amplitudes in both models, however, the 4-cin effect
on amplitude was much greater in ANCC than in NC (from
46.88 ± 3.38 pA, to 40.36 ± 3.62 pA, n = 8 in NC and
from 51.95 ± 4.24 pA to 38.41 ± 2.27 pA in ANCC,
p < 0.05, Figure 3) but the amplitude ranges in the scatter
plots largely overlapped in the two models (Figures 3C–D2).
There was no effect of 4-cin on the mIPSC time course
both in NC and ANCC (data not shown). Thus, blockade of
Pyg affected mIPSCs frequency in ANCC only whereas MCT
inhibition reduced mIPSCs frequency both in NC and in ANCC
and this effect was accompanied by amplitude reduction in
both models.
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FIGURE 3 | Blocker of glycogenphosphorylase, BAY reduces mIPSC
frequency in ANCC and induces a slight increase in mIPSC
amplitude both in NC and ANCC. Frequency of mIPSCs in NC is not
affected by BAY treatment (A) but in ANCC a strong decrease in mIPSC
frequency is observed in the presence of this compound (B). In (B1),
scatter plot of data for which averaged values are shown in (B). (C),
statistics for BAY effect on mIPSC amplitudes in NC. (C1,C2) show
scatter plot and cumulative distribution, respectively for data for which
averages are presented in (C). (D), statistics for BAY effect on mIPSC
amplitudes in ANCC. (D1,D2) show scatter plot and cumulative
distribution, respectively for data for which averages are presented in (D).
Asterisks indicate significant difference between respective groups.
The Effect of Glutamine Synthetase Inhibition
To check for the impact of Glns inhibition we used l-methionine
sulfoxide (MSO) at a final concentration of 1 mM. Treatment
with MSO resulted in a significant reduction of mIPSC frequency
in ANCC (control—0.44 ± 0.02 Hz, n = 15; MSO 0.14 ±
0.02 Hz, n = 13, p < 0.05, Figures 5A,A1) whereas in NC
no significant MSO effect was observed (p > 0.05, data not
shown). Notably, reduction of mIPSC frequency by MSO in
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FIGURE 4 | Blocker of MCT transporters, 4-cin, reduces mIPSC
frequency and amplitudes both in NC and ANCC. (A,B) Statistics of 4-cin
effect on mIPSC frequency in NC (A) and in ANCC (B). In (A1,B1), scatter plots
are presented for data for which averaged values are shown in (A,B),
respectively. (C), statistics for the effect of 4-cin on mIPSC amplitude in NC.
(C1,C2) show scatter plot and cumulative distribution, respectively for data for
which averages are presented in (C). (D), statistics for 4-cin effect on mIPSC
amplitudes in ANCC. (D1,D2) show scatter plot and cumulative distribution,
respectively for data for which averages are presented in (D). Asterisks indicate
significant difference between respective groups.
ANCC was similar to that observed between NC and ANCC
in control conditions. Treatment with MSO had no effect on
mIPSC amplitudes or their time course (data not shown).
As already mentioned, Glns mediates catalytic conversion of
glutamate to glutamine which is released from astrocytes and
taken up by neurons where it is subsequently converted into
respective neurotransmitters. Thus, considering this scenario, it
is expected that exogenous administration of glutamine should
prevent the reduction of mIPSC frequency in the presence of
MSO. However, supplementation of the external solution with
1 mM glutamine (concentration in astrocyte growth media)
resulted in only a partial, although statistically significant, rescue
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of mIPSC frequency (to 0.23 ± 0.03 Hz, n = 20, p < 0.05
Figure 5A). Notably, as shown in scatter plot (Figure 5A1)
administration of MSO to NACC resulted in disappearance
of high and appearance of extra low frequencies, whereas
exogenous glutamine shifted the range of frequencies upward
but highest frequency values observed in control ANCC were
not present in this group. In addition, although MSO had
no effect on mIPSC amplitudes (51.05 ± 6.00 pA, n = 15
in ANCC, 47.91 ± 4.72 pA, n = 15 in ANCC with MSO
and 51.49 ± 2.52 pA, p > 0.05, n = 20 with glutamine
supplementation, p > 0.05)or kinetics (data not shown), in
the case of MSO treated ANCC, supplementation with 1 mM
glutamine resulted in a significant shortening of the weighted
decay time constant (for ANCC 38.08 ± 1.93 ms n = 15, for
ANCC treated with MSO, 38.00± 2.92 ms, n = 15 and for ANCC
treated with MSO and 1 mM glutamine supplementation, 32.4±
0.83 ms, n = 20; Figure 5B). Taken altogether, Glns inhibition
resulted in a reduction of mIPSCs frequency only in ANCC and
this effect could be partially reversed by exogenous glutamine
administration.
The Effect of Inhibition Astrocytic Krebs Cycle
with Fluoroacetate
To investigate the impact of Krebs cycle in astrocytes on
GABAergic transmission we used fluoracaetate (FA) which
is a selective inhibitor of aconitase. Incubation of NC and
ANCC in the presence of 1 µM FA strongly reduced the mean
mIPSC frequency only in ANCC without any impact on mIPSC
frequency in NC (from 0.44 ± 0.08 Hz, n = 10 in control
ANCC to 0.04 ± 0.005 Hz, n = 9, after FA treatment, p < 0.05,
Figures 6A/A1), without any significant effect on mean mIPSC
amplitude in both NC and ANCC and its cumulative distribution
didn’t show any significant difference in both cases (data not
shown). FA had no effect on rise time of mIPSC in NC or ANCC
(data not shown) but it had a statistically significant effect on
decay time in both NC (from 41.17 ± 1.65 ms n = 10 in control
to 32.64± 4.38 ms, n = 9 in FA, p< 0.05, Figure 5B) and ANCC
(from 38.25 ± 1.93 ms, n = 10 in control to 30.06 ± 2.43 ms,
n = 9 in FA p < 0.05 Figure 6C). Thus, blocking the Krebs
cycle by aconitase inhibition resulted in a reduction of mIPSC
frequency in ANCC only and, additionally, an acceleration of
synaptic current decay both in NC and ANCC was observed.
Discussion
The most important finding of this study is that astrocytes
strongly up regulate GABAergic transmission in the model
of cultured hippocampal neurons. This effect was manifested
by a nearly fourfold increase in mIPSC frequency while
neither the amplitude nor current time course were affected,
suggesting a presynaptic mechanism. However, up regulation
of mIPSC frequency may potentially involve formation of new
synapses and increase in spontaneous release probability of
a single synaptic vesicle. Our immunofluorescence staining
showed increased number of GAD65 and vGAT puncta in
ANCC, providing evidence that the presence of astrocytes up
regulates the number of GABAergic synapses. However, it
should be noted that increase in synaptic puncta in ANCC
was considerably smaller than that for mIPSC frequency.
Although immunofluorescence staining cannot be regarded as
a strictly quantitative approach (an unknown proportion of
synaptic puncta is not detected), it is tempting to propose
that it provides a reasonable estimate of increased proportion
of synapses in ANCC. This suggests that increased number
of synapses might be responsible only for a part of increased
mIPSC frequency in ANCC. The mechanism underlying such
a strong impact of astrocytes on mIPSCs remains unknown
and, in general, astrocyte-neuronal cross talk in the context
of mIPSC frequency regulation remains poorly understood. It
has been proposed, for instance, that it might be related to
the modulation of calcium fluxes affecting the intracellular
calcium and thereby the release probability (Araque et al., 1998).
It is also known that GABAergic synaptic transmission may
depend on glutamate uptake (Mathews and Diamond, 2003;
Potapenko et al., 2013) which is strongly supported by astrocytes
but in these studies, the major observed effect was on IPSC
amplitudes.
Importantly, a strong increase in mIPSCs frequency in ANCC
was largely abolished by inhibition of Pyg, Glns or aconitase,
underscoring the importance of these key enzymes in neuronal-
astrocytic cross-talk. Pyg can be expressed both in astrocytes
and in neurons (Pellegri et al., 1996; Pfeiffer-Guglielmi et al.,
2003) raising a possibility that inhibition of glycogen cleavage in
astrocytes was not the only mechanism underlying the observed
effect of BAY U6751 in ANCC. However, BAY U6751 was
ineffective in NC indicating that neuronal Pyg was not essential
for the observed effect.Interestingly, inhibition of Pyg has also
been reported by our group to affect glutamatergic synaptic
currents although in that case, blockade of this enzyme reduced
mEPSC amplitude with no effect on frequency or time course
(Mozrzymas et al., 2011) indicating a different but, as yet,
unknown mechanism. It seems plausible, however, that it might
involve so called lactate shuttle (Magistretti and Pellerin, 1999)
which postulates that glycogen is broken by Pyg to glucoso-6-
phosphate and then transformed to lactate, released and taken up
by neurons by monocarboxylate (MCT) transporters (Halestrap
and Meredith, 2004; Pierre and Pellerin, 2005). It is possible
that astrocytes could affect the expression of neuronal MCT
in our model although studies performed on layered cultures
by Debernardi et al. (2003) did not indicate any clear effect of
astrocytes on MCT expression and distribution (Pellerin et al.,
2005).
Similar to BAY U6751, 4-cin, a blocker of monocarboxylate
transporters, reduced mIPSC frequency in NACC but in contrast
to the Pyg inhibitor, it also affected current amplitudes both
in NC and ANCC. In another model (retina) it has been
reported by Bui et al. (2004) that 4-cin treatment resulted in
a decreased GABA, glutamate and glutamine level. It is thus
likely that observed here decrease in mIPSC amplitudes might
result from reduction of neurotransmitter pool after inhibition
of lactate import by neurons. As already mentioned, astrocyte-
derived lactate is the major energy source for neurons and
it is likely that inhibition of its uptake by neurons triggers
redirection of glutamine from neurotransmitters synthesis to
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FIGURE 5 | Block of glutamine synthetase with MSO reduces mIPSC
frequency in ANCC. (A), statistics of MSO effect on mIPSC frequency (black
bar—control conditions, open bar—in the presence of MSO, gray bar in the
presence of MSO and 1 mM glutamine). (A1) shows a scatter plot for data for
which averages are presented in (A). (B), statistics for the weighted decay time
constants in the three groups considered in A. Note that in the presence of
MSO and 1 mM glutamine, mIPSCs decay is slightly but significantly
accelerated. Asterisks indicate significant difference between respective groups.
FIGURE 6 | Block of the Krebs cycle with fluoroacetatereduces
mIPSC frequency and accelerates decay kinetics in ANCC.
(A), statistics of FA effect on mIPSC frequency (black bar—control
conditions, open bar—in the presence of FA). (A1) shows a scatter plot
for data for which averages are presented in (A). (C,B) statistics for the
weighted decay time constants for controls recorded from ANCC (filled
circles) and in the presence of FA (open Bar). Asterisks indicate
significant difference between respective groups.
mitochondria for energy production and hence, it results in lower
GABA content in vesicles. However, mIPSC amplitude reduction
was also observed in NC (although to a much smaller extent),
where the mechanism based on astrocyte derived lactate is not
expected to occur. Nevertheless, as mentioned in Methods, our
primary neuronal cell cultures could contain a small (10%–15%)
astrocytic contamination which might potentially support a
residual of effect observed in NACC.
Interestingly, BAY treatment caused an increase of mean
mIPSC amplitude both in ANCC and in NC (Figure 3).
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Sickmann et al. (2012) have reported that the block of glycogen
degradation in diabetic rats resulted in an increase of GABA pool,
a result compatible with our observation of increased mIPSC
amplitude. It should be also considered that in contrast to 4-
cin, which regulates the entrance of lactate into neurons, BAY
U6751 affects the intracellular production of glycogen-derived
intermediates, (i.e., not only lactate) and, it is not surprising that
their effects could be different. Although astrocytes are regarded
as a main source of glycogen-derived metabolites in NACC, it
was also shown that neurons may synthesize and degrade lactate
to a modest extent (Suzuki et al., 2011; Hertz et al., 2014). Thus,
it might be hypothesized that glycogen-derived lactate, both from
astrocytes and/or neurons, is somehow involved in the regulation
of GABA/glutamate ratio in neurons. However, there are studies
showing that lactate does not play any substantial role in the
regulation of neuronal excitability (Ivanov et al., 2014). It cannot
be excluded that lactate and enzymes involved in the Krebs cycle
might affect the reversal potential for GABA-induced currents
(e.g., Holmgren et al., 2010; Tyzio et al., 2011) and thereby to
affect the network activity. This issue would require a thorough
measurements using perforated patch technique. We plan to
pursue this issue by using the perforated patch recording along
with the ultrastructural studies and quantal analysis.
In our experiments the blockade of Glns with MSO
reduced mIPSC frequency in NACC but not in NC and
theiramplitudes in both models were unchanged. The lack
of MSO effect on mIPSC amplitudes indicates that vesicular
GABA content was not affected. This observation suggests
that neurons are endowed with efficient buffering systems,
capable to assure physiological quantal size, even in conditions
of prolonged glutamine deficit. Presumably the inhibition of
glutamine turnover between astrocytes and neurons did not
affect, within the time scale of our experiments (1 h), GABA
content in synaptic vesicles, but the deficit of astrocyte-
derived glutamine reduced the pool of readily releasable
vesicles and decreased the number of functional synapses.
Precise estimation of contributions from these mechanisms will
require further investigations focused on synaptic mechanisms.
Interestingly, supplementation of MSO containing medium
with glutamine rescued the mIPSC frequency only partially
(Figure 5A), although glutamine concentration used in these
experiments (1 mM) was markedly larger than that measured
in hippocampal area (193.4 µM; Lerma et al., 1986) and
cortical region (385 ± 16 µM; Kanamori and Ross, 2004).
However, Boulland et al. (2002) have reported that GABAergic,
glutamatergic and glycinergic synaptic boutons are ensheated
by astrocytic processes characterized by a particularly high
expression of glutamine transporter SN1. Thus, it is possible
that exogenous glutamine administration does not fully mimic
specific conditions characterizing subtle interactions between
tiny astrocytic processes and the presynaptic boutons, where
glutamine transfer is expected to be crucial. Another of our
observations indicating that supplementation with exogenous
glutamine does not fully reproduce astrocyte-neuronal exchange
of this aminoacid is the fact that glutamine administration in
the presence of MSO affected mIPSC decay kinetics both in NC
and in NACC (Figure 5B) whereas these parameters in control
conditions and upon MSO treatment were indistinguishable.
Thus, administration of glutamine seems to trigger an additional
modulatory effect resulting in shorter mIPSC duration. The
mechanism underlying this observation remains unknown.
In our study we found that FA, a compound blocking Krebs
cycle enzyme, aconitase, and thereby ATP synthesis, strongly
down regulated mIPSCs frequency. Importantly, FA is taken up
mainly by astrocytes (Muir et al., 1986; Paulsen et al., 1987; Hassel
et al., 1992). Just recently, it has been demonstrated that ATP
released from astrocytes may increase mIPSC by activation of
metabotropic purynergic receptors (Torres et al., 2012). Thus,
our findings of a strong FA-induced depression of GABAergic
activity in ANCC could reflect the abolition of ATP release
from astrocytes. Also it is worth mentioning that FA can affect
glutamine-glutamate cycle by preventing glutamine formation
by Glns in astrocytes (Cheng et al., 1972; Paulsen et al., 1987)
and thereby may lower total GABA pool (Waagepetersen et al.,
1999). Our studies also revealed that FA accelerated mIPSC
deactivation both in NC and ANCC (Figures 6B/C). Recently,
Christian and Huguenard (2013) reported a similar effect of
fluorocitrate in thalamic reticular nucleus and attributed it
to an allosteric modulation of α3 subunit-containing GABAA
receptors. However, in hippocampus, similar effects of astrocyte-
released endozepines have not been described so far although
diazepam binding inhibitor protein expression was reported in
various brain structures including hippocampus (Yanase et al.,
2002). Thus, a similar effect to that reported by Christian and
Huguenard (2013) cannot be excluded in our model.
Taking altogether, we report that astrocytes strongly regulated
GABAergic transmission by affecting mainly the frequency
of mIPSCs. Our pharmacological data strongly suggest that
this impact of astrocytes on GABAergic transmission involves
regulation of key enzymes involved in cellular metabolism.
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